ClinicalTrials.Veeva

Menu

Mid-point Transverse Process to Pleura Block for Breast Cancer Surgery: A Randomized Controlled Trial

O

Ottawa Hospital Research Institute

Status

Enrolling

Conditions

Breast Cancer
Acute Pain
Anesthesia

Treatments

Procedure: Control Group
Procedure: MTP block group
Procedure: PVB group

Study type

Interventional

Funder types

Other

Identifiers

NCT03713255
20180259-01H

Details and patient eligibility

About

This study will compare the analgesic effects of midpoint transverse process to pleura (MTP) block to control as well as thoracic paravertebral block.

Full description

Paravertebral blocks (PVBs) are frequently used for regional anesthesia for breast surgery. Ultrasound-guided paravertebral block is an advanced skill. The needle tip can be difficult to visualize with ultrasound, and the proximity to neurovascular structures as well as the pleura presents a risk of neurovascular injection and pneumothorax respectively. The midpoint transverse-process to pleura (MTP) block incorporates a novel needle endpoint that is technically easier to achieve and more distant from neurovascular structures and the pleura compared to traditional PVB. This study will compare the analgesic effects of MTP block to control and PVB.

Enrollment

150 estimated patients

Sex

Female

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • English or French Speaking
  • Scheduled for major breast surgery
  • ASA physical status classification I-III
  • BMI <30kg/m2

Exclusion criteria

  • Prior ipsilateral breast surgery
  • Pre-existing neurological deficit or peripheral neuropathy involving the ipsilateral chest
  • Contraindications to regional anesthesia
  • Patient refusal of regional technique
  • Chronic pain disorder
  • Chronic opioid use
  • Inability to provide informed consent

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

150 participants in 3 patient groups

PVB group
Active Comparator group
Description:
paravertebral blocks with 0.5% ropivacaine and epinephrine 2.5 mcg/mL
Treatment:
Procedure: PVB group
MTP block group
Experimental group
Description:
MTP blocks with 0.5% ropivacaine and epinephrine 2.5 mcg/mL
Treatment:
Procedure: MTP block group
control group
Sham Comparator group
Description:
local anesthetic infiltration subcutaneous 1% lidocaine
Treatment:
Procedure: Control Group

Trial contacts and locations

1

Loading...

Central trial contact

Ioana Costache, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems